271 related articles for article (PubMed ID: 30335505)
1. Long-term mortality is increased in patients with undetected prediabetes and type-2 diabetes hospitalized for worsening heart failure and reduced ejection fraction.
Pavlović A; Polovina M; Ristić A; Seferović JP; Veljić I; Simeunović D; Milinković I; Krljanac G; Ašanin M; Oštrić-Pavlović I; Seferović PM
Eur J Prev Cardiol; 2019 Jan; 26(1):72-82. PubMed ID: 30335505
[TBL] [Abstract][Full Text] [Related]
2. Prediabetes and insulin resistance in a population of patients with heart failure and reduced or preserved ejection fraction but without diabetes, overweight or hypertension.
Son TK; Toan NH; Thang N; Le Trong Tuong H; Tien HA; Thuy NH; Van Minh H; Valensi P
Cardiovasc Diabetol; 2022 May; 21(1):75. PubMed ID: 35568879
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post-Hoc Analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) Trial.
Dauriz M; Targher G; Temporelli PL; Lucci D; Gonzini L; Nicolosi GL; Marchioli R; Tognoni G; Latini R; Cosmi F; Tavazzi L; Maggioni AP;
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679559
[TBL] [Abstract][Full Text] [Related]
4. Association between type-2 diabetes mellitus and post-discharge outcomes in heart failure patients: findings from the RICA registry.
Carrasco-Sánchez FJ; Gomez-Huelgas R; Formiga F; Conde-Martel A; Trullàs JC; Bettencourt P; Arévalo-Lorido JC; Pérez-Barquero MM;
Diabetes Res Clin Pract; 2014 Jun; 104(3):410-9. PubMed ID: 24768593
[TBL] [Abstract][Full Text] [Related]
5. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
Slee A; Saad M; Saksena S
J Interv Card Electrophysiol; 2019 Sep; 55(3):325-331. PubMed ID: 30887281
[TBL] [Abstract][Full Text] [Related]
6. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
Carson PE; Anand IS; Win S; Rector T; Haass M; Lopez-Sendon J; Miller A; Teerlink JR; White M; McKelvie RS; Komajda M; Zile MR; McMurray JJ; Massie B
JACC Heart Fail; 2015 Jun; 3(6):429-441. PubMed ID: 25982110
[TBL] [Abstract][Full Text] [Related]
7. Sex-specific clinical outcomes of impaired glucose status: A long follow-up from the Tehran Lipid and Glucose Study.
Parizadeh D; Rahimian N; Akbarpour S; Azizi F; Hadaegh F
Eur J Prev Cardiol; 2019 Jul; 26(10):1080-1091. PubMed ID: 30862232
[TBL] [Abstract][Full Text] [Related]
8. Type 2 diabetes and heart failure: Characteristics and prognosis in preserved, mid-range and reduced ventricular function.
Johansson I; Dahlström U; Edner M; Näsman P; Rydén L; Norhammar A
Diab Vasc Dis Res; 2018 Nov; 15(6):494-503. PubMed ID: 30176743
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical Outcomes.
Kristensen SL; Jhund PS; Lee MMY; Køber L; Solomon SD; Granger CB; Yusuf S; Pfeffer MA; Swedberg K; McMurray JJV;
Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):545-549. PubMed ID: 28948430
[TBL] [Abstract][Full Text] [Related]
10. Predictors and Prognostic Value of Worsening Renal Function During Admission in HFpEF Versus HFrEF: Data From the KorAHF (Korean Acute Heart Failure) Registry.
Kang J; Park JJ; Cho YJ; Oh IY; Park HA; Lee SE; Kim MS; Cho HJ; Lee HY; Choi JO; Hwang KK; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29535141
[TBL] [Abstract][Full Text] [Related]
11. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
[TBL] [Abstract][Full Text] [Related]
12. Type 2 diabetes increases the long-term risk of heart failure and mortality in patients with atrial fibrillation.
Polovina M; Lund LH; Đikić D; Petrović-Đorđević I; Krljanac G; Milinković I; Veljić I; Piepoli MF; Rosano GMC; Ristić AD; Ašanin M; Seferović PM
Eur J Heart Fail; 2020 Jan; 22(1):113-125. PubMed ID: 31822042
[TBL] [Abstract][Full Text] [Related]
13. Effect of functional electrical stimulation on cardiovascular outcomes in patients with chronic heart failure.
Kadoglou NP; Mandila C; Karavidas A; Farmakis D; Matzaraki V; Varounis C; Arapi S; Perpinia A; Parissis J
Eur J Prev Cardiol; 2017 May; 24(8):833-839. PubMed ID: 28079427
[TBL] [Abstract][Full Text] [Related]
14. Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial.
Greene SJ; Hernandez AF; Dunning A; Ambrosy AP; Armstrong PW; Butler J; Cerbin LP; Coles A; Ezekowitz JA; Metra M; Starling RC; Teerlink JR; Voors AA; O'Connor CM; Mentz RJ
J Am Coll Cardiol; 2017 Jun; 69(25):3029-3039. PubMed ID: 28641792
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study.
Iorio A; Senni M; Barbati G; Greene SJ; Poli S; Zambon E; Di Nora C; Cioffi G; Tarantini L; Gavazzi A; Sinagra G; Di Lenarda A
Eur J Heart Fail; 2018 Sep; 20(9):1257-1266. PubMed ID: 29917301
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and prognosis of heart failure with mid-range ejection fraction: insights from a multi-centre registry study in China.
Lyu S; Yu L; Tan H; Liu S; Liu X; Guo X; Zhu J
BMC Cardiovasc Disord; 2019 Sep; 19(1):209. PubMed ID: 31477021
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction.
Givertz MM; Stevenson LW; Costanzo MR; Bourge RC; Bauman JG; Ginn G; Abraham WT;
J Am Coll Cardiol; 2017 Oct; 70(15):1875-1886. PubMed ID: 28982501
[TBL] [Abstract][Full Text] [Related]
18. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
Farmakis D; Simitsis P; Bistola V; Triposkiadis F; Ikonomidis I; Katsanos S; Bakosis G; Hatziagelaki E; Lekakis J; Mebazaa A; Parissis J
Clin Res Cardiol; 2017 May; 106(5):359-368. PubMed ID: 27999929
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.
Chioncel O; Lainscak M; Seferovic PM; Anker SD; Crespo-Leiro MG; Harjola VP; Parissis J; Laroche C; Piepoli MF; Fonseca C; Mebazaa A; Lund L; Ambrosio GA; Coats AJ; Ferrari R; Ruschitzka F; Maggioni AP; Filippatos G
Eur J Heart Fail; 2017 Dec; 19(12):1574-1585. PubMed ID: 28386917
[TBL] [Abstract][Full Text] [Related]
20. Association of pulse rate with outcomes in heart failure with reduced ejection fraction: a retrospective cohort study.
Kurgansky KE; Schubert P; Parker R; Djousse L; Riebman JB; Gagnon DR; Joseph J
BMC Cardiovasc Disord; 2020 Feb; 20(1):92. PubMed ID: 32101141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
